Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07567417

Endocrinal Dysfunction Among Children With Dilated Cardiomyopathy

All patients in this study will be subjected to the following (as detailed in the attached patient's data sheet).

1. Clinical History: focusing on:

* Socio-demographic factors, especially age, gender, family history, and degree of consanguinity. * Cardiac symptoms, such as feeding difficulties in the infant, exercise intolerance in older children, fatigue, dyspnea on exertion, heart failure symptoms. 2. Thorough clinical examination: focusing on:

* General condition. * Anthropometric measures (weight, height, and body mass index). * Vital signs (Including HR, BP, SO2, RR, Body temperature). * Cardiac examination (including any associated murmur, signs up heart failure). 3. Severity of heart failure in children with dilated cardiomyopathy For all patients, they were classified according to Children's Ross HF classification.

Children's Ross HF classification is as follows[17]:

Class I: asymptomatic cases.

Class II: mild tachypnea or diaphoresis with feeding in infants, dyspnea on exertion in older children.

Class III: marked tachypnea or diaphoresis with feeding in infants, marked dyspnea on exertion, and prolonged feeding times with growth failure.

Class IV: tachypnea, retractions, grunting, or diaphoresis at rest are examples of symptoms. 4. Data collection: according to attached checklist for every patient involved in the study

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

1 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pediatric department at Sohag University hospital

Sohag, Egypt

Location contact

Nourhan Elsayed

CONTACT

01122317103

About this study

Dilated cardiomyopathy is defined as "dilatation and impaired contraction of the left or both ventricles with normal wall thickness" . It is characterized by systolic dysfunction with reduced myocardial contractility . DCM is the third leading cause of heart failure in pediatrics 3. The exact etiology of DCM is unknown in more than half of the cases and the term idiopathic DCM is used after exclusion of all the well-known etiologies of DCM as viral infections, autoimmune, genetic, endocrinal, and metabolic diseases .

DCM is typically diagnosed when patients present with heart failure symptoms, typically related to left ventricle systolic dysfunction, but right systolic dysfunction may accompany left ventricle failure . About 8-15% of patients will present with cardiac arrest, or with near-arrest requiring emergent resuscitation. In the remainder of patients, the most common symptom is shortness of breath (50%), followed by gastrointestinal upset and fatigue that is reported in a third of patients. Symptoms of an upper respiratory tract infection are also common. Echocardiography is the gold standard for diagnosis of DCM .

Methods:

All patients in this study will be subjected to the following (as detailed in the attached patient's data sheet).

  • Clinical History: focusing on:
  • Socio-demographic factors, especially age, gender, family history, and degree of consanguinity.
  • Cardiac symptoms, such as feeding difficulties in the infant, exercise intolerance in older children, fatigue, dyspnea on exertion, heart failure symptoms.
  • Thorough clinical examination: focusing on:
  • General condition.
  • Anthropometric measures (weight, height, and body mass index).
  • Vital signs (Including HR, BP, SO2, RR, Body temperature).
  • Cardiac examination (including any associated murmur, signs up heart failure).
  • Severity of heart failure in children with dilated cardiomyopathy For all patients, they were classified according to Children's Ross HF classification.

Children's Ross HF classification is as follows[17]:

Class I: asymptomatic cases.

Class II: mild tachypnea or diaphoresis with feeding in infants, dyspnea on exertion in older children.

Class III: marked tachypnea or diaphoresis with feeding in infants, marked dyspnea on exertion, and prolonged feeding times with growth failure.

Class IV: tachypnea, retractions, grunting, or diaphoresis at rest are examples of symptoms.

  • Data collection: according to attached checklist for every patient involved in the study
  • Investigations: focusing on
  • Laboratory investigations (IGF-1, free T3 and T4, TSH, morning serum cortisol and ACTH, 25 OH vit D, total and ionized calcium, serum parathyroid hormones levels, serum prolactin, serum electrolytes as Na, K). Samples to be withdrawn from cases and controls at 9:00 a.m. at the Pediatric Cardiology Unit, Sohag University Hospital.
  • Echocardiography assessment including:

Ejection fraction

Fractional shortening

Left ventricular end systolic diameter

Left ventricular end diastolic diameter

Mitral valve closure to opening time

Left ventricular ejection time

Mitral valve ejection

Mitral valve area

E/A ratio Mitral valve

Myocardial performance index of Left ventricular

  • Possible Therapeutic Modalities given to patients in the study Medical treatment (e.g .Anti-failure medications: Diuretics, ACE inhibitors,..etc.)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children aged 1 to 12 years diagnosed with dilated cardiomyopathy by Echocardiography.

Control: Age and sex match children attending Pediatric cardiology clinic with acute non serious illness to be included as Control

Exclusion criteria

  • Other types of cardiomyopathy (As hypertrophic, restrictive cardiomyopathy and other types).

Dilatation of Left ventricle due to other congenital or rheumatic heart diseases

Treatment and study plan

Echocardiography assessment.

Diagnostic Test

Assessment of Ejection fraction, Fractional shortening, and LV diameters/volumes to confirm diagnosis and severity.

Laboratory investigations and Hormone assessment.

Diagnostic Test

Blood samples will be collected at 9:00 a.m. to measure IGF-1, free T3 and T4, TSH, morning serum cortisol, ACTH, 25 OH vit D, calcium, parathyroid hormones, prolactin, and electrolytes (Na, K).

Primary outcomes

  1. Assessment of endocrine parameters in children with dilated cardiomyopathy

    Time frame: One year

    Insulin growth factor to be withdrawn from patient with dilated cardiomyopathy by venipuncture

Study contacts

Contact information is provided by the study sponsor or research team.

Nourhan Elsayed, Pediatric resident at Sohag Un

CONTACT

[email protected]

01122317103

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Endocrinal Dysfunction Among Children With Dilated Cardiomyopathy at Sohag University Hospital

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
May 5, 2026
Registry last updated
May 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.